Mendelian susceptibility to mycobacterial infection in man. 1998

F Altare, and E Jouanguy, and S Lamhamedi, and R Döffinger, and A Fischer, and J L Casanova
Institut National de la Santé et de la Recherche Médicale, Unité 429, Hôpital Necker-Enfants Malades, Paris, France.

Selective susceptibility to poorly pathogenic mycobacteria, such as bacille Calmette-Guérin vaccine and environmental non-tuberculous mycobacteria, has long been suspected to be a mendelian disorder but its molecular basis has remained elusive. Recently, recessive mutations in the interferon-gamma-receptor receptor ligand-binding chain, interferon-gamma-receptor signalling chain, IL-12 p40 subunit and IL-12-receptor beta 1 chain genes have been identified in a number of patients with disseminated mycobacterial infection. Although genetically distinct, these conditions are immunologically related and highlight the essential role of interferon-gamma-mediated immunity in the control of mycobacteria in man.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D009164 Mycobacterium Infections Infections with bacteria of the genus MYCOBACTERIUM. Infections, Mycobacterium,Infection, Mycobacterium,Mycobacterium Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D053707 Receptors, Interleukin-12 Cell surface receptors for INTERLEUKIN-12. They exist as dimers of beta 1 and beta 2 subunits. Signaling from interleukin-12 receptors occurs through their interaction with JANUS KINASES. IL-12 Receptors,Interleukin-12 Receptors,IL-12 Receptor,Interleukin-12 Receptor,Receptor, Interleukin-12,IL 12 Receptor,IL 12 Receptors,Interleukin 12 Receptor,Interleukin 12 Receptors,Receptor, IL-12,Receptor, Interleukin 12,Receptors, IL-12,Receptors, Interleukin 12
D018123 Receptors, Interleukin Cell surface proteins that bind interleukins and trigger intracellular changes influencing the behavior of cells. Interleukin Receptors,Interleukin Receptor,Receptors, Interleukins,Interleukins Receptors,Receptor, Interleukin
D018664 Interleukin-12 A heterodimeric cytokine that plays a role in innate and adaptive immune responses. Interleukin-12 is a 70 kDa protein that is composed of covalently linked 40 kDa and 35 kDa subunits. It is produced by DENDRITIC CELLS; MACROPHAGES and a variety of other immune cells and plays a role in the stimulation of INTERFERON-GAMMA production by T-LYMPHOCYTES and NATURAL KILLER CELLS. Edodekin Alfa,IL-12,Natural Killer Cell Stimulatory Factor,Cytotoxic Lymphocyte Maturation Factor,IL 12,IL-12 p70,IL12,Interleukin 12,Interleukin-12 p70,Interleukin 12 p70
D020022 Genetic Predisposition to Disease A latent susceptibility to disease at the genetic level, which may be activated under certain conditions. Genetic Predisposition,Genetic Susceptibility,Predisposition, Genetic,Susceptibility, Genetic,Genetic Predispositions,Genetic Susceptibilities,Predispositions, Genetic,Susceptibilities, Genetic

Related Publications

F Altare, and E Jouanguy, and S Lamhamedi, and R Döffinger, and A Fischer, and J L Casanova
August 2001, Swiss medical weekly,
F Altare, and E Jouanguy, and S Lamhamedi, and R Döffinger, and A Fischer, and J L Casanova
November 2000, Microbes and infection,
F Altare, and E Jouanguy, and S Lamhamedi, and R Döffinger, and A Fischer, and J L Casanova
January 2011, Clinical genetics,
F Altare, and E Jouanguy, and S Lamhamedi, and R Döffinger, and A Fischer, and J L Casanova
January 2006, Respiration; international review of thoracic diseases,
F Altare, and E Jouanguy, and S Lamhamedi, and R Döffinger, and A Fischer, and J L Casanova
November 2000, Microbes and infection,
F Altare, and E Jouanguy, and S Lamhamedi, and R Döffinger, and A Fischer, and J L Casanova
June 2020, Human genetics,
F Altare, and E Jouanguy, and S Lamhamedi, and R Döffinger, and A Fischer, and J L Casanova
January 2012, Mediterranean journal of hematology and infectious diseases,
F Altare, and E Jouanguy, and S Lamhamedi, and R Döffinger, and A Fischer, and J L Casanova
January 2010, Annals of thoracic medicine,
F Altare, and E Jouanguy, and S Lamhamedi, and R Döffinger, and A Fischer, and J L Casanova
April 2019, Immunology and cell biology,
F Altare, and E Jouanguy, and S Lamhamedi, and R Döffinger, and A Fischer, and J L Casanova
December 2008, The Journal of allergy and clinical immunology,
Copied contents to your clipboard!